$PBH
AI Sentiment Score: 0/100|1 articles (7d)|USD
Open
$55.62
Day High
$57.05
Day Low
$54.75
Prev Close
$55.62
Volume
536K
Sentiment
0
0B · 1Be
Intraday Price Chart · 5-Min Candles
79 data points · Dashed line = EOD prediction
EOD Prediction
$54.45
-1.11 (-2.00%) vs now
AI Signal
▼ SELL
EOD prediction is AI-generated from news sentiment only. Not financial advice.
Latest Analysis for $PBH
Want to slash your taxes in retirement? These 5 countries make it possible — and some cost far less than the U.S.
The article discusses five countries that offer favorable tax environments for retirees looking to reduce their tax burden compared to the U.S. It highlights options that range from no income tax to lower tax rates, which could appeal to American retirees. By relocating to these countries, retirees might enjoy a better quality of life at a lower cost. The provided insights could stimulate interest in international real estate and investment in expatriate resources. Overall, the article encourages financial planning for retirement that extends beyond domestic borders.
Prestige Consumer Healthcare’s (PBH) Free Cash Flow to Enterprise Value Stood at 6.5%
Prestige Consumer Healthcare reported a free cash flow to enterprise value ratio of 6.5%, indicating solid cash generation relative to its market value. This metric suggests that the company has a healthy capital structure and potential for growth. Investors may view this ratio positively as it reflects the company's ability to generate cash for expansion or dividends. Market reactions may be influenced by this strong indicator of financial health. Overall, this could lead to bullish sentiment among investors and analysts.
Prestige Consumer Healthcare Inc. (PBH) Breathe Right - M&A Call - Slideshow
Prestige Consumer Healthcare Inc. (PBH) held a call regarding its Breathe Right product line, outlining the strategic importance of this brand in enhancing market penetration and product offerings. The M&A discussion indicates a focus on potential acquisitions that could bolster their portfolio. Analysts see this as a move to strengthen PBH's competitive position in the healthcare sector. The company's commitment to expanding its product lines is expected to drive revenue growth. Overall, the news highlights PBH's proactive approach to growth through strategic acquisitions.
Prestige Consumer Healthcare: Adding A Prestigious Brand
Prestige Consumer Healthcare has announced the acquisition of a well-known brand, which is expected to enhance its product portfolio and market presence. The strategic move is anticipated to drive revenue growth and improve profitability in the coming quarters. Analysts believe this acquisition positions the company favorably against competitors. Investors are reacting positively to the news, leading to increased trading volume in its shares. Overall, the acquisition signals a commitment to expansion and innovation within the healthcare sector.

Prestige Consumer to buy Breathe Right brand in $1.05 billion deal
Prestige Consumer announced its acquisition of the Breathe Right brand for $1.05 billion, signaling a significant expansion into the nasal health market. This deal aims to leverage Breathe Right's established presence to enhance Prestige Consumer's product portfolio. Analysts have a generally positive outlook on the acquisition as it is expected to drive revenue growth and market share. However, concerns have been raised about the high valuation and integration costs. Overall, this move could bolster Prestige's competitive positioning in the sector.
Premium Brands Holdings Corporation 2025 Q4 - Results - Earnings Call Presentation
Premium Brands Holdings Corporation reported its Q4 results for 2025, showcasing a mixed performance amidst challenges in the food sector. Revenues increased slightly, but net profits took a hit due to rising input costs and supply chain disruptions. The company emphasized a focus on expanding its product lines to offset these challenges and tapped into new market opportunities. Despite the hurdles, management expressed optimism for recovery in the subsequent quarters. Analysts anticipate a turnaround if the company can successfully implement its growth strategy.